Abbott beats profit estimate on diagnostics, diabetes device boost

0
3

Excluding one-off items, the healthcare giant reported a profit of $1.03 per share for the fourth quarter ended Dec. 31, higher than the average of analysts’ estimate of 92 cents.

The company also announced an adjusted profit forecast of $4.30 to $4.50 per share for 2023.

Investing
Read More